Bristol-Myers Squibb Company vs Prologis, Inc.
Market cap comparison over time
Bristol-Myers Squibb Company
$129.9B
Rank #132
Prologis, Inc.
$132.6B
Rank #129
Market Cap Over Time
Key Moments
- Prologis, Inc. overtook Bristol-Myers Squibb Company by 2005
- Bristol-Myers Squibb Company overtook Prologis, Inc. by 2008
- Prologis, Inc. overtook Bristol-Myers Squibb Company by 2021
- Bristol-Myers Squibb Company overtook Prologis, Inc. by 2022
- Prologis, Inc. overtook Bristol-Myers Squibb Company by 2023
- Bristol-Myers Squibb Company overtook Prologis, Inc. by 2024
- Prologis, Inc. overtook Bristol-Myers Squibb Company by 2025
Year-by-Year Comparison
| Year | Bristol-Myers Squibb Company | Prologis, Inc. | Leader |
|---|---|---|---|
| 2026 | $129.9B | $132.6B | Prologis, Inc. |
| 2025 | $107.8B | $117.2B | Prologis, Inc. |
| 2024 | $107.6B | $93.6B | Bristol-Myers Squibb Company |
| 2023 | $92.9B | $114.6B | Prologis, Inc. |
| 2022 | $125.8B | $94.2B | Bristol-Myers Squibb Company |
| 2021 | $105.8B | $137.5B | Prologis, Inc. |
| 2020 | $102.0B | $79.7B | Bristol-Myers Squibb Company |
| 2019 | $102.4B | $69.4B | Bristol-Myers Squibb Company |
| 2018 | $80.2B | $44.5B | Bristol-Myers Squibb Company |
| 2017 | $92.0B | $47.5B | Bristol-Myers Squibb Company |
| 2016 | $85.4B | $37.6B | Bristol-Myers Squibb Company |
| 2015 | $98.2B | $29.5B | Bristol-Myers Squibb Company |
| 2014 | $82.3B | $28.5B | Bristol-Myers Squibb Company |
| 2013 | $72.0B | $23.7B | Bristol-Myers Squibb Company |
| 2012 | $42.7B | $22.7B | Bristol-Myers Squibb Company |
| 2011 | $44.4B | $17.2B | Bristol-Myers Squibb Company |
| 2010 | $31.8B | $18.4B | Bristol-Myers Squibb Company |
| 2009 | $28.9B | $14.2B | Bristol-Myers Squibb Company |
| 2008 | $25.1B | $12.4B | Bristol-Myers Squibb Company |
| 2007 | $27.1B | $29.3B | Prologis, Inc. |
| 2006 | $25.9B | $28.9B | Prologis, Inc. |
| 2005 | $21.6B | $23.4B | Prologis, Inc. |
| 2004 | $23.0B | $18.4B | Bristol-Myers Squibb Company |
| 2003 | $24.5B | $14.3B | Bristol-Myers Squibb Company |
| 2002 | $19.0B | $11.2B | Bristol-Myers Squibb Company |
| 2001 | $40.3B | $10.1B | Bristol-Myers Squibb Company |
| 2000 | $54.6B | $9.4B | Bristol-Myers Squibb Company |
| 1999 | $46.6B | $6.8B | Bristol-Myers Squibb Company |
| 1998 | $48.0B | $7.0B | Bristol-Myers Squibb Company |
| 1997 | $33.4B | $7.6B | Bristol-Myers Squibb Company |